High-dose vitamin D supplementation reduces disease activity in clinically isolated syndrome typical of MS, results of a ...
The medication, which will be rolled out to patients with relapsing-remitting MS, is thought to be the first in Europe to be ...
"It was important to conduct a large randomized controlled trial to evaluate the efficacy of high-dose cholecalciferol as ...
Thousands of NHS patients in England with multiple sclerosis (MS) are set to benefit from a life-changing ‘take at home’ tablet, as the NHS becomes the first healthcare system in Europe to roll it out ...
M.S. is a disease of the brain and spinal cord that affects almost a million people in the United States. About 1,200 here in ...
WEST PALM BEACH, Fla. — New research testing the newly proposed McDonald Criteria showed that 32% more patients with a ...
Black people with MS walk slower and cover shorter distances than white patients, even when some social determinants are ...
Revisions made in 2024 to the McDonald criteria allowed for the diagnosis of multiple sclerosis in a small cohort of ...
Irish and Finnish researchers found that users became more aware of their fatigue patterns, allowing them to plan their lives ...
Relapses were thought to drive disability progression with RRMS, but PIRA may be an important contributor, affecting patients ...
To address these inconsistencies, my colleagues and I used what researchers call a bedside-to-bench-to-bedside approach: ...
You disconnect your cell phone from its charger as you get ready for a busy day. But even though it has been connected all night, the battery is only partially charged. You look at ...